Pfizer rethinking U.S. expansion if drug pricing orders implemented

Pfizer Inc <PFE.N> Chief Executive Albert Bourla said the drugmaker could rethink plans to expand in the United States if the country implements an executive order signed by President Donald Trump last week that would tie the prices Medicare patients pay for drugs to those paid by other countries.